West Pharmaceutical Services Inc (WST)

Payables turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Cost of revenue (ttm) US$ in thousands 1,893,300 1,871,900 1,848,800 1,840,500 1,820,600 1,813,400 1,773,200 1,760,600 1,750,700 1,734,300 1,733,700 1,692,400 1,655,800 1,594,700 1,529,800 1,453,400 1,379,100 1,327,400 1,282,300 1,262,000
Payables US$ in thousands
Payables turnover

December 31, 2024 calculation

Payables turnover = Cost of revenue (ttm) ÷ Payables
= $1,893,300K ÷ $—K
= —

The data provided for West Pharmaceutical Services Inc's payables turnover indicates that the payables turnover ratio is not available (\u2014) for all the reported periods from March 31, 2020, to December 31, 2024. The payables turnover ratio is a financial metric used to assess how efficiently a company manages its accounts payable by measuring how quickly a company pays its suppliers.

Without the specific values for the payables turnover ratio, it is challenging to provide a detailed analysis of West Pharmaceutical Services Inc's ability to manage its payables effectively. The payables turnover ratio typically reflects the relationship between a company's cost of goods sold and its average accounts payable balance.

In cases where the payables turnover ratio is not available, it may indicate that the specific data required to calculate this ratio is not disclosed or may not be applicable due to specific circumstances within the company.

To gain a deeper understanding of West Pharmaceutical Services Inc's payables management efficiency, more detailed financial data or information regarding the company's payables practices would be necessary for further analysis.


Peer comparison

Dec 31, 2024

Company name
Symbol
Payables turnover
West Pharmaceutical Services Inc
WST
Carlisle Companies Incorporated
CSL